Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$3.3 - $4.83 $2.18 Million - $3.2 Million
-661,720 Reduced 35.83%
1,185,273 $4.84 Million
Q2 2023

Aug 11, 2023

SELL
$3.23 - $4.95 $4.17 Million - $6.39 Million
-1,290,700 Reduced 41.14%
1,846,993 $6.26 Million
Q1 2023

May 12, 2023

BUY
$2.68 - $4.79 $7.2 Million - $12.9 Million
2,688,000 Added 597.74%
3,137,693 $15 Million
Q4 2022

Feb 13, 2023

BUY
$1.22 - $2.85 $238,441 - $557,015
195,444 Added 76.87%
449,693 $1.28 Million
Q3 2022

Nov 14, 2022

BUY
$0.59 - $1.44 $26,701 - $65,168
45,256 Added 21.65%
254,249 $303,000
Q2 2022

Aug 12, 2022

SELL
$0.51 - $1.17 $554,166 - $1.27 Million
-1,086,600 Reduced 83.87%
208,993 $123,000
Q1 2022

May 13, 2022

SELL
$0.65 - $1.18 $484,138 - $878,897
-744,828 Reduced 36.5%
1,295,593 $1.39 Million
Q4 2021

Feb 11, 2022

BUY
$0.86 - $1.7 $1.75 Million - $3.47 Million
2,040,421 New
2,040,421 $2.24 Million
Q2 2021

Aug 13, 2021

SELL
$6.55 - $8.98 $3.27 Million - $4.48 Million
-499,273 Closed
0 $0
Q1 2021

May 13, 2021

SELL
$6.1 - $7.69 $1.61 Million - $2.03 Million
-263,594 Reduced 34.55%
499,273 $3.31 Million
Q4 2020

Feb 10, 2021

SELL
$5.05 - $7.1 $1.54 Million - $2.17 Million
-304,947 Reduced 28.56%
762,867 $4.94 Million
Q3 2020

Nov 13, 2020

SELL
$5.25 - $7.08 $3.26 Million - $4.4 Million
-621,520 Reduced 36.79%
1,067,814 $5.61 Million
Q2 2020

Aug 13, 2020

SELL
$5.37 - $8.11 $1.6 Million - $2.42 Million
-298,000 Reduced 14.99%
1,689,334 $11.7 Million
Q1 2020

May 14, 2020

SELL
$4.35 - $8.79 $2.07 Million - $4.18 Million
-475,900 Reduced 19.32%
1,987,334 $11.3 Million
Q4 2019

Feb 13, 2020

BUY
$4.23 - $8.29 $131,553 - $257,818
31,100 Added 1.28%
2,463,234 $18.5 Million
Q3 2019

Nov 13, 2019

BUY
$2.15 - $6.28 $713,937 - $2.09 Million
332,064 Added 15.81%
2,432,134 $11.4 Million
Q2 2019

Aug 12, 2019

BUY
$2.49 - $3.73 $294,985 - $441,885
118,468 Added 5.98%
2,100,070 $5.65 Million
Q1 2019

May 14, 2019

SELL
$1.88 - $3.35 $408,183 - $727,348
-217,119 Reduced 9.87%
1,981,602 $5.55 Million
Q4 2018

Feb 13, 2019

BUY
$1.66 - $4.16 $3.65 Million - $9.15 Million
2,198,721 New
2,198,721 $3.94 Million

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $815M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.